
Newt Gingrich @newtgingrich
This is because PBMs use bigger copays to steer patients toward lower priced drugs. Patient assistance is seen as undermining that steering. But the new rule would turn a patient benefit into an insurance company/PBM benefit. Actually makes the middlemen problem worse. (2 or 3) — PolitiTweet.org